Arkolith/Insider Trading/VOR/Form 4

Ra Capital Management, L.P.

Director, 10% OwnerVor Biopharma Inc. (VOR) · full profile →Form 4 · filed Oct 27, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6.2M
Net Open-Market Flow
-$6.2M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 27, 2025Sell(S)91K$28.12$2.6M1.2M
Oct 24, 2025Sell(S)53K$28.01$1.5M1.3M
Oct 23, 2025Sell(S)77K$28.01$2.2M1.3M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-25-000359) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML